Rhythm Biosciences An ASX Life Sciences Growth Opportunity 6 AUGUST 2026 – 20 TH BIOSHARES BIOTECH SUMMIT Disclaimer This presentation has been prepared by Rhythm Biosciences Limited (Rhythm) and is provided for general information purposes only. No party other than Rhythm has...
Bioshares 2026 Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
In the deck
Story so far
Earlier from Rhythm Biosciences
- Quarterly Activities Report and Appendix 4C
- Response to ASX Query Letter
- First ColoSTAT Clinical Test Sale
- NATA Accredits ColoSTAT Clinical Testing Service
- RHY Executes SE Asian Genetype Distribution Agreement
Later from Rhythm Biosciences
- ColoSTAT Commercial Rollout Update
- Notification of cessation of securities - RHY
- Appointment of Non-Executive Directors
- FY26 Appendix 4E & Audited Financial Report
- Initial Director's Interest Notice - Maureen Baker
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences